Ken Fisher's CRNX Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 758,659 shares of Crinetics Pharmaceuticals, Inc. (CRNX) worth $35.32 M, representing 0.01% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in CRNX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 387,435 shares. Largest reduction occurred in Q2 2025, reducing 36,263 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Crinetics Pharmaceuticals (CRNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Crinetics Pharmaceuticals (CRNX) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +302 | Add 0.04% | 758,659 | $46.55 |
| Q3 2025 | +21,273 | Add 2.89% | 758,357 | $41.65 |
| Q2 2025 | -36,263 | Reduce 4.69% | 737,084 | $28.76 |
| Q1 2025 | +214,060 | Add 38.27% | 773,347 | $33.54 |
| Q4 2024 | +77,188 | Add 16.01% | 559,287 | $51.13 |
| Q3 2024 | +37,429 | Add 8.42% | 482,099 | $51.10 |
| Q2 2024 | +8,647 | Add 1.98% | 444,670 | $44.79 |
| Q1 2024 | -5,272 | Reduce 1.19% | 436,023 | $46.81 |
| Q4 2023 | +387,435 | Add 719.34% | 441,295 | $35.58 |
| Q3 2023 | -14,411 | Reduce 21.11% | 53,860 | $29.74 |
| Q1 2023 | -8,653 | Reduce 11.25% | 68,271 | $16.06 |
| Q4 2022 | +23,568 | Add 44.17% | 76,924 | $18.30 |
| Q3 2022 | +53,356 | New Buy | 53,356 | $19.64 |
Ken Fisher's Crinetics Pharmaceuticals Investment FAQs
Ken Fisher first purchased Crinetics Pharmaceuticals, Inc. (CRNX) in Q3 2022, acquiring 53,356 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Crinetics Pharmaceuticals, Inc. (CRNX) for 14 quarters since Q3 2022.
Ken Fisher's largest addition to Crinetics Pharmaceuticals, Inc. (CRNX) was in Q4 2023, adding 441,295 shares worth $15.7 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 758,659 shares of Crinetics Pharmaceuticals, Inc. (CRNX), valued at approximately $35.32 M.
As of the Q4 2025 filing, Crinetics Pharmaceuticals, Inc. (CRNX) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Crinetics Pharmaceuticals, Inc. (CRNX) was 773,347 shares, as reported at the end of Q1 2025.